***Based on a 6-month clinical trial (n=180) of individuals who were enrolled between FebruaryApril 2024, with overweight or obesity taking semaglutide or tirzepatide for weight loss and related outcomes through the WW Clinic Program and participating in the GLP-1 companion nutrition program
Chemical modifications, such as amino acid mutations, addition of fatty acid chains, or design of synthetic analogs, can enhance their resistance to enzymatic degradation and significantly improve metabolic stability and half-life (Yu et al., 2018
Sofwave: Your Non-Surgical Answer to Support Skin Elasticity Pure Impact: Rebuild Muscle, Regain Strength Disclaimer: Results may vary according to skin condition, laxity and other individual characteristics
Peptidyl and Non-Peptidyl Oral Glucagon-Like Peptide-1 Receptor Agonists
Its approach combines: Psychology-based daily lessons and mindset tools grounded in behavioral science Coaching and accountability support Food, weight, and habit tracking in a single app Access to licensed clinicians through the Noom Med program Multiple medical pathways, including full-dose GLP-1s, microdose GLP-1s, and oral weight-loss medications Ongoing guidance for side-effect management, appetite changes, and long-term habit maintenance Within Noom Med, prescription optionsincluding injectables, oral medications, and microdose alternativesare integrated directly into the behavior-change program
WeightWatchers Clinic provides eligible members seamless access to: Personalized, timely, specialized support that helps members with their weight management goals along with access to FDA-approved medications, if deemed eligible
